Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Diabetes treatments have differential effects on nontraditional cardiovascular risk factors.

Fonseca VA, Theuma P, Mudaliar S, Leissinger CA, Clejan S, Henry RR.

J Diabetes Complications. 2006 Jan-Feb;20(1):14-20.

PMID:
16389162
2.

Immune responses induced by intranasal imiquimod and implications for therapeutics in rhinovirus infections.

Clejan S, Mandrea E, Pandrea IV, Dufour J, Japa S, Veazey RS.

J Cell Mol Med. 2005 Apr-Jun;9(2):457-61.

3.

Vesicle traffic through intercellular bridges in DU 145 human prostate cancer cells.

Vidulescu C, Clejan S, O'connor KC.

J Cell Mol Med. 2004 Jul-Sep;8(3):388-96.

4.

Spatial composition of prostate cancer spheroids in mixed and static cultures.

Song H, David O, Clejan S, Giordano CL, Pappas-Lebeau H, Xu L, O'Connor KC.

Tissue Eng. 2004 Jul-Aug;10(7-8):1266-76.

PMID:
15363181
5.

Novel ceramide analogs as potential chemotherapeutic agents in breast cancer.

Struckhoff AP, Bittman R, Burow ME, Clejan S, Elliott S, Hammond T, Tang Y, Beckman BS.

J Pharmacol Exp Ther. 2004 May;309(2):523-32. Epub 2004 Jan 23.

PMID:
14742741
6.

Immunohistochemical analysis of differentiation in static and mixed prostate cancer spheroids.

Song H, O'Connor KC, David O, Giordano CL, Pappas-LeBeau H, Clejan S.

J Cell Mol Med. 2003 Apr-Jun;7(2):180-6.

7.

Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis.

Clejan S, Japa S, Clemetson C, Hasabnis SS, David O, Talano JV.

J Cell Mol Med. 2002 Oct-Dec;6(4):583-92.

8.

Prediction of respiratory distress syndrome using the Abbott FLM-II amniotic fluid assay.

Kaplan LA, Chapman JF, Bock JL, Santa Maria E, Clejan S, Huddleston DJ, Reed RG, Bernstein LH, Gillen-Goldstein J.

Clin Chim Acta. 2002 Dec;326(1-2):61-8. Review.

PMID:
12417097
9.
10.

Transmission of HCV to a chimpanzee using virus particles produced in an RNA-transfected HepG2 cell culture.

Dash S, Kalkeri G, McClure HM, Garry RF, Clejan S, Thung SN, Murthy KK.

J Med Virol. 2001 Oct;65(2):276-81.

PMID:
11536233
11.

Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions.

Burow ME, Weldon CB, Collins-Burow BM, Ramsey N, McKee A, Klippel A, McLachlan JA, Clejan S, Beckman BS.

J Biol Chem. 2000 Mar 31;275(13):9628-35.

12.

Analysis of molecular species of cellular sphingomyelins and ceramides.

Clejan S.

Methods Mol Biol. 1998;105:275-85. Review. No abstract available.

PMID:
10427570
13.
14.

Analytical methods and steps to sample preparation for determination of molecular species of fatty acids.

Clejan S.

Methods Mol Biol. 1998;105:243-53. Review. No abstract available.

PMID:
10427568
15.

Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants.

Burow ME, Weldon CB, Tang Y, Navar GL, Krajewski S, Reed JC, Hammond TG, Clejan S, Beckman BS.

Cancer Res. 1998 Nov 1;58(21):4940-6.

16.
18.

Erythropoietin stimulates nuclear localization of diacylglycerol and protein kinase C beta II in B6SUt.EP cells.

Mallia CM, Smith M, Clejan S, Beckman BS.

J Lipid Mediat Cell Signal. 1997 Dec;17(3):135-50.

PMID:
9524923
19.
20.

Effects of simulated microgravity on DU 145 human prostate carcinoma cells.

Clejan S, O'Connor KC, Cowger NL, Cheles MK, Haque S, Primavera AC.

Biotechnol Bioeng. 1996 Jun 5;50(5):587-97.

PMID:
18627022
21.

The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.

Jaspan JB, Sullivan K, Garry RF, Lopez M, Wolfe M, Clejan S, Yan C, Tenenbaum S, Sander DM, Ahmed B, Bryer-Ash M.

J Clin Endocrinol Metab. 1996 Jun;81(6):2271-9.

PMID:
8964863
22.

Electromagnetic field induced changes in lipid second messengers.

Clejan S, Ide C, Walker C, Wolf E, Corb M, Beckman B.

J Lipid Mediat Cell Signal. 1996 May;13(3):301-24.

PMID:
8816991
23.

Morphological differentiation of N1E-115 neuroblastoma cells by dimethyl sulfoxide activation of lipid second messengers.

Clejan S, Dotson RS, Wolf EW, Corb MP, Ide CF.

Exp Cell Res. 1996 Apr 10;224(1):16-27.

PMID:
8612681
24.

Molecular species of phospholipids in a murine stem-cell line responsive to erythropoietin.

Beckman BS, Mallia C, Clejan S.

Biochem J. 1996 Mar 15;314 ( Pt 3):861-7.

25.

Erythropoietin stimulates G-protein-coupled phospholipase D in haematopoietic target cells.

Clejan S, Mallia C, Vinson D, Dotson R, Beckman BS.

Biochem J. 1996 Mar 15;314 ( Pt 3):853-60.

26.

Gastric carcinoma: recent issues in prognostic factors.

Chen BF, Marrogi AJ, Freeman SM, Clejan S.

J La State Med Soc. 1995 Apr;147(4):138-45.

PMID:
7775839
28.

Isolation of Tn917 insertional mutants of Bacillus subtilis that are resistant to the protonophore carbonyl cyanide m-chlorophenylhydrazone.

Quirk PG, Guffanti AA, Clejan S, Cheng J, Krulwich TA.

Biochim Biophys Acta. 1994 Jun 28;1186(1-2):27-34.

PMID:
8011666
29.
30.
31.

Signal transduction by the erythropoietin receptor: evidence for the activation of phospholipases A2 and C.

Mason-Garcia M, Clejan S, Tou JS, Beckman BS.

Am J Physiol. 1992 May;262(5 Pt 1):C1197-203.

PMID:
1317100
32.

Interaction of cholesterol with conformationally restricted phospholipids in vesicles.

Bittman R, Fugler L, Clejan S, Lister MD, Hancock AJ.

Biochim Biophys Acta. 1992 Apr 29;1106(1):40-4.

PMID:
1581334
33.

The effect of digital rectal examination on prostate-specific antigen levels.

Crawford ED, Schutz MJ, Clejan S, Drago J, Resnick MI, Chodak GW, Gomella LG, Austenfeld M, Stone NN, Miles BJ, et al.

JAMA. 1992 Apr 22-29;267(16):2227-8.

PMID:
1372943
34.

Digital rectal examination-associated alterations in serum prostate-specific antigen.

Thomson RD, Clejan S.

Am J Clin Pathol. 1992 Apr;97(4):528-34.

PMID:
1372788
35.

Prostate specific antigen and prostatitis. II. PSA production and release kinetics in vitro.

Moon TD, Clejan S, Neal DE Jr.

Prostate. 1992;20(2):113-6.

PMID:
1372427
36.
37.
39.
40.

Protonophore-resistance and cytochrome expression in mutant strains of the facultative alkaliphile Bacillus firmus OF4.

Quirk PG, Guffanti AA, Plass RJ, Clejan S, Krulwich TA.

Biochim Biophys Acta. 1991 Jun 17;1058(2):131-40.

PMID:
1646630
43.
46.
47.
48.
49.

Isolation and characterization of uncoupler-resistant mutants of Bacillus subtilis.

Guffanti AA, Clejan S, Falk LH, Hicks DB, Krulwich TA.

J Bacteriol. 1987 Oct;169(10):4469-78.

50.

Supplemental Content

Loading ...
Support Center